August 30, 2016 9:27 PM ET

Biotechnology

Company Overview of Capricor Therapeutics, Inc.

Key Executives for Capricor Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Linda Marban Ph.D.18 RelationshipsCo-Founder, Chief Executive Officer, President and Director53
Frank Litvack M.D., FACC64 RelationshipsExecutive Chairman and Chairman of Compensation Committee60
Eduardo Marban M.D., Ph.D.37 RelationshipsCo-Founder and Chairman of Scientific Advisor Board--
Leland J. Gershell M.D., Ph.D.No RelationshipsChief Financial Officer and Principal Financial Officer44
Deborah D. Ascheim M.D.No RelationshipsChief Medical Officer51
View More Key Executives

Capricor Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Frank Litvack M.D., FACC 64 RelationshipsCapricor Therapeutics, Inc.60
Linda Marban Ph.D. 18 RelationshipsCapricor Therapeutics, Inc.53
Eduardo Marban M.D., Ph.D. 37 RelationshipsCapricor Therapeutics, Inc.--
Earl M. Collier Jr., J.D., Esq. 89 RelationshipsCapricor Therapeutics, Inc.69
George W. Dunbar Jr. 72 RelationshipsISTO Technologies, Inc.69
View All Board Members

Capricor Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Compensation Committee M.D., FACCFrank Litvack64 Relationships4 Executives
Nominating Committee Jr., J.D., Esq.Earl M. Collier89 Relationships2 Executives
Corporate Governance Committee Jr., J.D., Esq.Earl M. Collier89 Relationships2 Executives
Advisory Board M.D., Ph.D.Eduardo Marban37 Relationships12 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$232.9K
232.9K
380.0K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$232.9K
232.9K
33.9M
Compensation as of Fiscal Year 2015
Capricor Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bone Therapeutics SA Appoints Benoît Champluvier as Chief Technology and Manufacturing Officer
August 30, 2016 5:00 AM ET
Adverum Biotechnologies, Inc. Announces Resignation of John P. McLaughlin as Member of the Board of Directors, Chairman and Member of the Audit Committee and Member of the Compensation and Nominating and Corporate Governance Committees of the Board, Effective as of August 31, 2016
August 29, 2016 8:44 PM ET
OncoCyte Corporation Announces Board Changes
August 29, 2016 8:15 PM ET
Leap Therapeutics, Inc. and Macrocure Ltd. Announce Management Changes
August 29, 2016 12:51 PM ET
FORMA Therapeutics, Inc. Appoints Karoline Shair as Vice President, Legal and Chief Intellectual Property Counsel
August 29, 2016 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Capricor Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.